Constraints on prostaglandin biosynthesis in tissues
- PMID: 3102488
Constraints on prostaglandin biosynthesis in tissues
Abstract
The formation of prostaglandins by prostaglandin H synthase can be limited by the availability of the fatty acid substrate or the hydroperoxide activator and also by a self-catalyzed inactivation associated with the oxygenation reaction. Each pmol of synthase appeared able to form only about 1300 pmol of prostaglandin from arachidonate before it was inactivated. This extent of synthesis was not diminished when substrate fatty acid was complexed with cytosolic proteins even though the velocity of the oxygenation reaction was greatly decreased by the lower availability of substrate acid. When the availability of hydroperoxide activator was decreased by added glutathione peroxidase, the extent of oxygenation per mol of synthase was decreased irrespective of the amount of cytosolic protein present. Approximately 65% of the total prostaglandin synthesis by homogenates was suppressed with a glutathione peroxidase to prostaglandin H synthase ratio of about 90. The remaining prostaglandin synthetic activity was more resistant, being completely suppressed only when the ratio of peroxidase to synthase exceeded 750. The overall ratio of glutathione peroxidase (peroxide-removing) capacity to prostaglandin synthetic (peroxide-forming) capacity in selected tissues ranged from over 1800 in rat liver to less than 30 in leukocytes. A comparison between the daily urinary output of prostaglandin metabolites and tissue prostaglandin synthetic capacity suggested that prostaglandin H synthase inactivation along with glutathione peroxidase suppression of the extent of prostaglandin synthase may be important in limiting prostaglandin biosynthesis within cells.
Similar articles
-
Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2.J Biol Chem. 1995 Oct 13;270(41):24019-23. doi: 10.1074/jbc.270.41.24019. J Biol Chem. 1995. PMID: 7592599
-
Detection of a higher oxidation state of manganese-prostaglandin endoperoxide synthase.J Biol Chem. 1992 Jul 15;267(20):13863-9. J Biol Chem. 1992. PMID: 1321128
-
Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.Mol Pharmacol. 1984 Sep;26(2):328-35. Mol Pharmacol. 1984. PMID: 6434940
-
The enzymology of prostaglandin endoperoxide H synthases-1 and -2.Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:115-28. doi: 10.1016/s0090-6980(02)00025-4. Prostaglandins Other Lipid Mediat. 2002. PMID: 12432913 Review.
-
Prostaglandin H synthase as a limiting enzyme of prostaglandin synthesis: substrate-induced inactivation as a new kind of enzyme activity regulation.Biotechnol Appl Biochem. 1993 Jun;17(3):291-304. Biotechnol Appl Biochem. 1993. PMID: 8338638 Review.
Cited by
-
Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells.J Clin Invest. 1989 Apr;83(4):1153-9. doi: 10.1172/JCI113995. J Clin Invest. 1989. PMID: 2495300 Free PMC article.
-
Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.Cardiovasc Drugs Ther. 1996 Sep;10(4):417-24. doi: 10.1007/BF00051106. Cardiovasc Drugs Ther. 1996. PMID: 8924055
-
Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress.J Am Chem Soc. 2010 Mar 24;132(11):3914-22. doi: 10.1021/ja910578y. J Am Chem Soc. 2010. PMID: 20196542 Free PMC article.
-
Clinical and therapeutic use of probucol.Eur J Clin Pharmacol. 1991;40 Suppl 1:S81-4. Eur J Clin Pharmacol. 1991. PMID: 2044650
-
Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.Proc Natl Acad Sci U S A. 1988 Mar;85(5):1412-6. doi: 10.1073/pnas.85.5.1412. Proc Natl Acad Sci U S A. 1988. PMID: 3125548 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources